Skip to main content
IONS logo
IONS
(NASDAQ)
Ionis Pharmaceuticals, Inc.
$74.79-- (--)
Loading... - Market loading

Ionis Pharmaceuticals (IONS) Stock Price & Financial Analysis

Ionis Pharmaceuticals Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$73.35 - $75.13
52-Week High$86.74
52-Week Low$23.95
Open$73.74
Volume1.79M
Average Volume (3M)1.79M
Market Cap12.12B
Shares Outstanding162.00M
Price to Sales (P/S)12.90
Price to Book (P/B)24.89
EV/EBITDA3.18
Revenue (TTM)943.38M
Net Income (TTM)-380.99M
Free Cash Flow (TTM)-324.30M
EPS (TTM)$-2.35
Profit Margin-40.39%
Operating Margin-40.52%
Return on Equity (ROE)-77.90%
Debt to Equity5.35
50-Day MA$78.67
200-Day MA$66.08
52-Week Change175.61%
Annual Dividend$0.00
Dividend Yield0.00%
Last Dividend Ex-DateFeb 17, 2000

Frequently Asked Questions About Ionis Pharmaceuticals

What is the current stock price for IONS?

As of the latest trading session, IONS stock trades at $74.79. The 52-week range is $23.95–$86.74, with a day range of $73.35–$75.13.

What is the P/E ratio for IONS?

The P/E ratio (Price-to-Earnings) for IONS is shown in the Key Statistics section. This valuation metric helps compare Ionis Pharmaceuticals, Inc. to industry peers.

Does IONS pay dividends?

Ionis Pharmaceuticals does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for IONS?

Based on 7 analysts, the consensus for IONS is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of IONS?

Ionis Pharmaceuticals's market capitalization is $12.12B, classifying it as a large-cap company. Ionis Pharmaceuticals operates in the Healthcare sector within the Biotechnology industry.